bioRxivBioinformaticsPreprint
Quantitative Donor Histology and Transcriptomics Link Pancreatic Composition and Precancers Across the Adult Lifespan
Valentina Matos-RomeroiD, Daniela Higuera-Garrido, Wen-Chen Chen, Andre ForjaziD, Ali Ataa, Salma Habib, Lucie Dequiedt, Paul Gensbigler, Data Science TeamLab, Arrate Munoz-BarrutiaiD, Denis Wirtz, Ralph H HrubaniD, Ashley L KiemeniD
Abstract
Background & Aims: Pancreatic intraepithelial neoplasia (PanIN) is the primary precursor to invasive pancreatic ductal adenocarcinoma (PDAC). While PanIN is common in the general population, PDAC is rare. PDAC risk rises with age, diabetes mellitus, and obesity, but whether this increased risk reflects a greater precancer burden is unknown, as previous studies assessed PanIN presence and grade. We aimed to quantify pancreatic composition and PanIN burden across the adult lifespan to identify demographics of donors carrying disproportionate precancer burden. Methods: We applied CODAvision, a deep-learning segmentation pipeline, to 410 high-quality pancreas sections from Genotype-Tissue Expression (GTEx) donors aged 21 to 70 years. We screened twenty-seven donor phenotypes against 14 compositional measures, applying Benjamini-Hochberg correction for multiple testing. We further related tissue composition and donor phenotype to bulk gene expression in 281 donors to understand which demographics are associated with a compositional or transcriptional fingerprint. Results: PanIN was present in 83% of donors. Acinar proportion declined with age, offset by fat and stroma. Median PanIN burden did not change with age, though the fitted 90th percentile rose from 0.21% to 0.72% of exocrine tissue (uncorrected P=.002). The 39 sections (10%) with high-outlier PanIN burden came disproportionately from donors with type 2 diabetes mellitus and hypertension and had greater stromal proportion and higher fibroblast and immune-cell densities. Both cell types were denser in peri-PanIN stroma than in the surrounding pancreatic parenchyma. PanIN abundance was associated with a gastric transcriptional signature including VSIG1, TFF1, and MUC5AC. Conclusions: Most donors carried little PanIN at any age, whereas high burden was concentrated in a minority of donors more likely to have type 2 diabetes mellitus, hypertension, and inflamed, fibrotic stroma. Because PanIN was present in most donors, its presence did not distinguish high-risk groups, whereas quantitative burden did, concentrating on the metabolic phenotypes already under consideration for pancreatic surveillance.
- organism: human
- assay: bulk RNA-seq
- research focus: cell type annotation
- research focus: differential expression
- approach: deep learning
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Analysis of donor pancreata defines the transcriptomic signature and microenvironment of early pre-neoplastic pancreatic lesions
E. S. Carpenter, A. M. Elhossiny, … M. Pasca Di Magliano·bioRxiv·Jan 13, 2023
- 3D histology reveals that immune response to pancreatic precancers is heterogeneous and depends on global pancreas structure
Ashley L. Kiemen, Cristina Almagro-Pérez, … Denis Wirtz·bioRxiv·Aug 3, 2024
- Integrative analysis of genomic and transcriptomic data informs precancer progression in the pancreas
Kathleen Noller, Jiaying Lai, … Elana Judith Fertig·bioRxiv·Nov 3, 2025
- Three-dimensional genomic mapping of human pancreatic tissue reveals striking multifocality and genetic heterogeneity in precancerous lesions
A. M. Braxton, A. L. Kiemen, … L. D. Wood·bioRxiv·Jan 27, 2023
- A transcriptionally distinct subpopulation of healthy acinar cells exhibit features of pancreatic progenitors and PDAC
Vishaka Gopalan, Arashdeep Singh, … Sridhar S. Hannenhalli·Cancer ResearchPeer-reviewed·May 28, 2021
- The Aging Microenvironment as a Determinant of Immune Exclusion and Metastatic Fate in Pancreatic Cancer
Priyanka Gupta, Rabi Murad, … Cosimo Commisso·bioRxiv·May 8, 2025